What is Rapport Therapeutics, Inc.'s enterprise value?

Rapport Therapeutics, Inc. (RAPP) reported enterprise value of $1.43B in Q1 2026.

How has Rapport Therapeutics, Inc.'s enterprise value changed year-over-year?

Rapport Therapeutics, Inc.'s enterprise value increased by 351.5% year-over-year, from $316.3M to $1.43B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

Rapport Therapeutics, Inc. RAPP Enterprise value

Enterprise value at other companies

Bristol-Myers SquibbBMY

$158.92B-2.6%

Supernus PharmaceuticalsSUPN

$2.83B+62.3%

Xenon PharmaceuticalsXENE

$5.01B+104%

Praxis Precision Medicines, Inc.PRAX

$8.44B+1,309%

BiohavenBHVN

$1.28B-46.3%

Septerna, Inc.SEPN

$1.03B+1,325%

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$24.2M+10.7%

Net income-$19.9M+17.5%

EPS (diluted)-$0.42+38.2%

Balance sheet

See full

Cash & equivalents$78.1M+35.5%

Total debt$10.8M+37.8%

Total equity$471.5M+65.0%

Total assets$497.6M+64.7%

Cash flow

See full

Operating cash flow-$13.1M+35.5%

CapEx$86.0K-70.4%

Free cash flow-$13.1M+36.0%

Valuation

See full

Market cap$1.86B+309%

Returns & leverage

See full

Return on equity-28.3%—

Debt / equity0×0.0×

Current ratio27.1×-3.9×

Where this comes from

Calculated from Rapport Therapeutics, Inc.’s reported figures.

$1.5Bmarket cap+$10.8Mtotal debt−$78.1Mcash and equivalents=$1.43B

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s enterprise value?: Rapport Therapeutics, Inc. (RAPP) reported enterprise value of $1.43B in Q1 2026.
How has Rapport Therapeutics, Inc.'s enterprise value changed year-over-year?: Rapport Therapeutics, Inc.'s enterprise value increased by 351.5% year-over-year, from $316.3M to $1.43B.
What does enterprise value mean?: Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.